Literature DB >> 32514153

NAFLD - sounding the alarm on a silent epidemic.

Jeffrey V Lazarus1,2, Massimo Colombo3,4, Helena Cortez-Pinto5, Terry T-K Huang6, Veronica Miller7, Michael Ninburg8,9, Jörn M Schattenberg10, Lynn Seim11, Vincent W S Wong12, Shira Zelber-Sagi13,14.   

Abstract

Mesh：

Year:  2020        PMID： 32514153     DOI： 10.1038/s41575-020-0315-7

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  4 in total

1.  A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.

Authors:  Jeffrey V Lazarus; Mattias Ekstedt; Giulio Marchesini; Jillian Mullen; Katja Novak; Juan M Pericàs; Elena Roel; Manuel Romero-Gómez; Vlad Ratziu; Frank Tacke; Helena Cortez-Pinto; Quentin M Anstee
Journal:  J Hepatol       Date:  2019-09-10       Impact factor: 25.083

Review 2.  Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.

Authors:  Thomas G Cotter; Mary Rinella
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

3.  Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.

Authors:  Eric Lawitz; Charles S Landis; Steven L Flamm; Maurizio Bonacini; Grisell Ortiz-Lasanta; Jonathan Huang; Jie Zhang; Brian J Kirby; Shampa De-Oertel; Robert H Hyland; Anu O Osinusi; Diana M Brainard; Richard Robson; Benedict J Maliakkal; Stuart C Gordon; Edward J Gane
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-06-10

4.  Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.

Authors:  Carolin V Schneider; Karim Hamesch; Annika Gross; Mattias Mandorfer; Linda S Moeller; Vitor Pereira; Monica Pons; Pawel Kuca; Matthias C Reichert; Federica Benini; Barbara Burbaum; Jessica Voss; Marla Gutberlet; Vivien Woditsch; Cecilia Lindhauer; Malin Fromme; Julia Kümpers; Lisa Bewersdorf; Benedikt Schaefer; Mohammed Eslam; Robert Bals; Sabina Janciauskiene; Joana Carvão; Daniel Neureiter; Biaohuan Zhou; Katharina Wöran; Heike Bantel; Andreas Geier; Timm Dirrichs; Felix Stickel; Alexander Teumer; Jef Verbeek; Frederik Nevens; Olivier Govaere; Marcin Krawczyk; Tania Roskams; Johannes Haybaeck; Georg Lurje; Joanna Chorostowska-Wynimko; Joan Genesca; Thomas Reiberger; Frank Lammert; Aleksander Krag; Jacob George; Quentin M Anstee; Michael Trauner; Christian Datz; Nadine T Gaisa; Helmut Denk; Christian Trautwein; Elmar Aigner; Pavel Strnad
Journal:  Gastroenterology       Date:  2020-05-04       Impact factor: 22.682
  4 in total
  22 in total

Review 1.  Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.

Authors:  Pau Vancells Lujan; Esther Viñas Esmel; Emilio Sacanella Meseguer
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

Review 2.  Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.

Authors:  Jörn M Schattenberg; Jeffrey V Lazarus; Philip N Newsome; Lawrence Serfaty; Alessio Aghemo; Salvador Augustin; Emmanuel Tsochatzis; Victor de Ledinghen; Elisabetta Bugianesi; Manuel Romero-Gomez; Heike Bantel; Stephen D Ryder; Jerome Boursier; Vincent Leroy; Javier Crespo; Laurent Castera; Lefteris Floros; Vincenzo Atella; Jorge Mestre-Ferrandiz; Rachel Elliott; Achim Kautz; Alice Morgan; Sally Hartmanis; Sharad Vasudevan; Lynne Pezzullo; Aldo Trylesinski; Sandrine Cure; Victoria Higgins; Vlad Ratziu
Journal:  Liver Int       Date:  2021-03-18       Impact factor: 5.828

3.  Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.

Authors:  Matt Docherty; Stephane A Regnier; Gorana Capkun; Maria-Magdalena Balp; Qin Ye; Nico Janssens; Andreas Tietz; Jürgen Löffler; Jennifer Cai; Marcos C Pedrosa; Jörn M Schattenberg
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

Review 4.  Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.

Authors:  Katherine Martin; Anas Hatab; Varinder S Athwal; Elliot Jokl; Karen Piper Hanley
Journal:  Curr Diab Rep       Date:  2021-02-05       Impact factor: 4.810

5.  Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals.

Authors:  Huajie Dai; Jiali Xiang; Yanan Hou; Liping Xuan; Tiange Wang; Mian Li; Zhiyun Zhao; Yu Xu; Jieli Lu; Yuhong Chen; Weiqing Wang; Guang Ning; Yufang Bi; Min Xu
Journal:  Nutr Metab (Lond)       Date:  2021-02-19       Impact factor: 4.169

6.  The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats.

Authors:  Yi Gao; Jia Zhang; Xiao Xiao; Yifan Ren; Xiaopeng Yan; Jing Yue; Tieyan Wang; Zheng Wu; Yi Lv; Rongqian Wu
Journal:  Front Cell Infect Microbiol       Date:  2021-04-02       Impact factor: 5.293

Review 7.  Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?

Authors:  Jalpa Devi; Aimun Raees; Amna Subhan Butt
Journal:  World J Hepatol       Date:  2022-01-27

8.  Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany.

Authors:  Christian Labenz; Karel Kostev; Leonard Kaps; Peter R Galle; Jörn M Schattenberg
Journal:  Dig Dis Sci       Date:  2020-10-10       Impact factor: 3.199

Review 9.  The use of comics to promote health awareness: A template using nonalcoholic fatty liver disease.

Authors:  Mireia Alemany-Pagès; Anabela Marisa Azul; João Ramalho-Santos
Journal:  Eur J Clin Invest       Date:  2021-06-30       Impact factor: 5.722

Review 10.  Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy.

Authors:  Maximiliano L Cacicedo; Carolina Medina-Montano; Leonard Kaps; Cinja Kappel; Stephan Gehring; Matthias Bros
Journal:  Cells       Date:  2020-08-28       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.